HIV-1 infection
Clinical research activity is centred on human immunodeficiency virus type 1, with a focus on ongoing treatment access for individuals living with HIV.
- Antiretroviral therapy
- Viral suppression
- Pediatric HIV care
The sponsor’s research interest in this area is directed toward maintaining therapeutic continuity for patients previously treated in pediatric HIV studies.
Rilpivirine-based treatment
The funded clinical activity is focused on rilpivirine within the context of ongoing antiretroviral treatment for HIV-1 infection.
- Continuation of therapy
- Long-term treatment access
- Treatment benefit maintenance
This area reflects interest in preserving clinical benefit for participants who have already received rilpivirine in prior pediatric research settings.
